SQZ Biotech Lines Up an IPO on the NYSE to Fund Cell Therapy R&D

SQZ Biotechnologies, which already has an alliance with Roche focused on developing new cancer cell therapies, is now looking to sell shares to the public to finance its research of potential new treatments for both cancer and infectious disease.